(HealthDay)—Compared with on-time dosing, delay of denosumab by more than 16 weeks is associated with an increased risk for vertebral […]
- Home
- denosumab
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok